6.12
Элиминация лекарств означает выведение препаратов из организма через мочу или желчь, почками или печенью соответственно. Фармакокинетический параметр,…
Лекарственное средство, поступающее в организм, выводится почками и печенью через мочу или желчь соответственно. Фармакокинетический параметр, клиренс препарата, определяет эффективность организма в выведении препарата в течение определенного периода.
Клиренс лекарственного средства определяется как удаление фиксированного объема лекарствосодержащей жидкости в единицу времени. Рассчитывается путем деления скорости выведения препарата из плазмы на концентрацию препарата в плазме, Cp.
Во время элиминации первого порядка подстановка скорости элиминации на kCpVd изменяет уравнение клиренса. Последующее уравнение показывает, что клиренс является произведением объема распределения, Vd, и константы скорости, k.
В результате снижение концентрации в плазме снижает скорость выведения препарата, но его клиренс остается постоянным.
Клиренс является важнейшим параметром при разработке рациональных схем приема лекарств и прогнозировании потенциальных побочных эффектов.
View the full transcript and gain access to JoVE Core videos
Q1: How is drug clearance calculated in pharmacokinetics?
Drug clearance is calculated by dividing the rate of drug elimination from plasma by the drug's plasma concentration. During first-order elimination, clearance equals the product of the volume of distribution and the rate constant. This calculation reveals how efficiently the body removes a fixed volume of drug-containing fluid per unit of time, which remains constant even as plasma concentration decreases.
Q2: What organs are involved in drug clearance?
Drug clearance involves multiple organs including the kidneys, liver, lungs, and biliary system. The kidneys eliminate drugs through urine, while the liver eliminates drugs through bile. The sum of clearances by all eliminating organs is called total body or systemic clearance, which can be expressed as a combination of renal clearance and nonrenal clearance.
Q3: Why does drug clearance remain constant despite changes in plasma concentration?
During first-order elimination, clearance is defined as the product of the volume of distribution and rate constant, making it independent of plasma concentration. Although a decrease in plasma concentration reduces the drug elimination rate, the clearance value itself stays constant because it represents the body's inherent capacity to remove the drug, not the absolute amount removed.
Q4: What happens when dosing rate exceeds the body's elimination capacity?
Exceeding the prescribed dosing rate overloads elimination pathways and decreases drug clearance efficiency. This leads to elevated plasma drug concentrations that can reach toxic levels and cause adverse effects. Understanding drug clearance is essential for designing effective dosage regimens and ensuring safe, optimal drug therapy tailored to individual needs.
Q5: How does drug clearance relate to drug regimen design?
Drug clearance is a crucial pharmacokinetic parameter for designing rational drug regimens and predicting potential side effects. By measuring the body's efficiency in removing drugs within a specific period, clinicians can determine appropriate dosing intervals and amounts. This allows for individualized adjustments based on a person's specific elimination capacity and needs.
Q6: What is the difference between renal and nonrenal clearance?
Renal clearance refers to drug elimination through the kidneys via urine, while nonrenal clearance encompasses elimination through other organs like the liver, lungs, and biliary system. Total body clearance is the sum of both renal and nonrenal clearance pathways. Understanding both components helps predict how individual organ function affects overall drug removal.
Q7: How do physicochemical properties influence drug clearance?
A drug's physicochemical properties affect how efficiently it is eliminated by the body's organs. These properties influence whether a drug undergoes renal excretion, hepatic metabolism, or other elimination pathways. Understanding factors affecting renal clearance drug's physicochemical properties and plasma levels helps predict clearance rates and optimize dosing strategies for different patient populations.